Forensic Accounting & Growth Decomposition Analysis — FY23 to 9M FY26 | Based on 3 Annual Reports, 13 Concall Transcripts & Acquisition Documents
Kaynes Technology India Ltd is an electronics manufacturing services (EMS) company that has demonstrated strong revenue growth over FY23-FY25 (CAGR ~58%). However, a forensic review reveals several areas warranting deep scrutiny: a rapidly expanding subsidiary structure with 11+ entities, aggressive M&A activity, expanding working capital days, massive inter-company lending (₹13,690 Mn to subsidiaries in FY25), a growing gap between standalone and consolidated financials, and management's own admission that the FY25 "other expense" surge was due to "reclassification" rather than genuine cost increases.
Overall Accounting Stance
Moderately Aggressive
Conservative ← → Aggressive
Growth Quality
Mixed — Core + Inorganic
Organic ← → Acquisition-Driven
Management Execution
Above Average
Poor ← → Excellent
| Particulars | FY23 | FY24 | FY25 | FY24 YoY% | FY25 YoY% |
|---|---|---|---|---|---|
| Revenue from Operations | 10,866 | 12,739 | 27,135 | +17% | +113% |
| Other Income | 117 | 642 | 227 | +449% | -65% |
| Total Income | 10,983 | 13,381 | 27,363 | +22% | +104% |
| Cost of Materials Consumed | 8,272 | 9,331 | 18,648 | +13% | +100% |
| Change in Inventories | (671) | (215) | (131) | — | — |
| Employee Benefit Expenses | 700 | 881 | 3,129 | +26% | +255% |
| Finance Cost | 344 | 535 | 187 | +56% | -65% |
| Depreciation & Amortisation | 177 | 214 | 375 | +21% | +75% |
| Other Expenses | 916 | 1,029 | 4,274 | +12% | +315% |
| Profit Before Tax | 1,245 | 1,606 | 937 | +29% | -42% |
| Tax Expense | 298 | ~404 | 226 | — | — |
| PAT | 948 | ~1,202 | 710 | +27% | -41% |
Note: FY25 standalone shows revenue doubling but PAT declining 41% — a critical divergence. Employee costs jumped 255% and other expenses 315%. See Section 9 for detailed investigation.
| Metric | Standalone | Consolidated | Gap | Interpretation |
|---|---|---|---|---|
| Revenue (₹ Mn) | 27,135 | 27,218 | +83 | Minimal Subsidiary Revenue |
| PBT (₹ Mn) | 937 | 1,075 | +138 | Subsidiaries Net Positive |
| PAT (₹ Mn) | 710 | 803 | +93 | Subsidiaries Profitable |
| Total Assets (₹ Mn) | 18,236 | 18,943 | +707 | Subsidiary Assets |
| Period | Order Book (₹ Mn) | ₹ Crore Equivalent | YoY Growth |
|---|---|---|---|
| Q4 FY24 | 41,152 | 4,115 | — |
| Q2 FY25 | 54,228 | 5,423 | +32% |
| Q3 FY25 | 60,471 | 6,047 | +11% |
| Q4 FY25 | 65,969 | 6,597 | +60% YoY |
| Q1 FY26 | 74,011 | 7,401 | +47% YoY |
| Q2 FY26 | 80,994 | 8,099 | +49% YoY |
| Q3 FY26 (9M) | ~90,000 | ~9,000 | +49% YoY |
Corrected: Management stated "around ₹90,000 million" in Q3 FY26 call (Feb 2026) = approximately ₹9,000 Crore, NOT ₹90,000 crore. All figures in ₹ millions as reported.
| Item | FY23 | FY24 | FY25 | Observation |
|---|---|---|---|---|
| Total Assets | 14,000 | 29,683 | 18,236 | FY24 bloated by IPO/QIP cash, normalized FY25 |
| Equity | 9,584 | 24,288 | 8,389 | Sharp drop FY25 — cash deployed into subs |
| Investments in Subsidiaries | 40 | 1,742 | 1,893 | 43x jump FY24 — M&A deploy |
| Loans to Subsidiaries (RPT) | — | ~2,246 | 13,690 | Massive inter-co lending |
| CWIP | 113 | 81 | 457 | 5.6x jump in FY25 — capex ramp |
| CWIP (Consolidated) | — | 766 | 3,002 | ₹3B in construction — see ECMS |
| Inventories | 4,016 | 4,726 | 3,482 | Improving in FY25 |
| Trade Receivables | 2,203 | 1,261 | 4,918 | 3.9x jump FY25! |
| Borrowings (Total) | 1,277 | 2,641 | 3,991 | Rising leverage |
Iskraemeco acquisition: Goodwill of ₹1,140 Mn and intangible assets of ₹1,150 Mn recognized. Sensonic acquisition: Goodwill/intangible of ₹511 Mn despite the entity having negative net assets of ₹(58) Mn. Management acknowledged classification ambiguity between goodwill and intangibles during the Dec 2025 business update, noting disclosure errors requiring reclassification.
H2 FY25 showed reported net margins of 28% for Iskraemeco — a figure management itself acknowledged was overstated due to inventory write-offs of ₹44 Cr in H1. Normalized margins estimated at ~10%. This kind of volatility raises questions about earnings consolidation quality.
₹140.81 Mn in R&D expenses capitalized in FY25 (₹68.41 Mn in FY24). Intangibles under development grew significantly. This is permissible under Ind AS 38, but management has significant discretion in determining when development reaches "commercial viability" stage.
When analysts asked about the 315% surge in other expenses, CFO Jairam Sampath explicitly stated on the Q4 FY25 call: "It has more to do with reclassification than to increase in cost." He mentioned "reclassification of certain consumables" that were previously part of bill of materials. This is a significant admission — reclassifying costs between line items (materials → other expenses) without clear disclosure can obscure true cost trends and makes year-over-year comparison meaningless.
Company capitalizes borrowing costs for qualifying assets (OSAT, PCB facilities). With ₹3,002 Mn in CWIP and major capex projects underway, the quantum of capitalized interest reduces reported finance costs. Finance costs actually fell 65% in FY25 despite total borrowings rising 51%.
Revenue recognized at point of delivery (Ind AS 115). For a company with multi-year contracts, this is conservative relative to percentage-of-completion. However, the Q3 FY25 call had management stating costs have "kicked in but revenues yet to kick in" for new businesses — suggesting timing mismatches.
Standalone trade receivables jumped from ₹1,261 Mn (FY24) to ₹4,918 Mn (FY25) — a 3.9x increase against revenue growing 2.1x. Consolidated receivables include ₹687 Cr from Iskraemeco customers with ₹250 Cr classified as non-current, requiring ECL provisioning of ₹193.51 Mn.
FIFO method at lower of cost or NRV — standard conservative practice. FY25 standalone inventory actually declined despite revenue doubling.
| Area | Policy | Stance | Impact |
|---|---|---|---|
| Revenue Recognition | Point-in-time delivery | Conservative | Revenue deferred until delivery |
| Inventory Valuation | FIFO, lower of cost/NRV | Conservative | Standard practice |
| Depreciation | Straight-line, standard lives | Neutral | No unusual rates |
| R&D Cost Capitalization | ₹141 Mn capitalized (FY25) | Aggressive | Inflates profit by deferring expense |
| Borrowing Cost Capitalization | Capitalized for qualifying assets | Moderate-Aggressive | Finance costs dropped 65% despite higher debt |
| Goodwill from M&A | ₹1,651 Mn total goodwill | Aggressive | High goodwill for entities with low/negative net assets |
| Expense Reclassification | "Consumables" reclassified out of BOM | Aggressive | Obscures true cost trends, YoY comparison broken |
| Working Capital Management | 87-132 days (expanding) | Concerning | Cash conversion deteriorating |
| Inter-Company Lending | ₹13,690 Mn loans to subs (FY25) | High Risk | Cash trapped in pre-revenue subsidiaries |
| Category | FY23 (₹ Mn) | FY24 (₹ Mn) | FY25 (₹ Mn) | Impact on Profits |
|---|---|---|---|---|
| R&D Expenses Capitalized | — | 68 | 141 | If expensed, PBT reduces by ₹141 Mn |
| Employee Costs Capitalized (R&D) | — | 53 | 54 | Salaries moved to intangible assets |
| Borrowing Costs (Capitalized est.) | — | ~80 | ~250 | Finance costs understated; fell 65% despite higher debt |
| CWIP (Preoperative Expenses) | 113 | 766 | 3,002 | Preoperative expenses parked in CWIP across group |
Borrowing cost capitalization estimated from the anomaly: total borrowings grew from ₹2,641 Mn to ₹3,991 Mn (+51%) but finance costs fell from ₹535 Mn to ₹187 Mn (-65%). Even after accounting for IPO proceeds repaying some debt, the magnitude suggests significant interest capitalization.
Below we restate FY25 consolidated financials by reversing aggressive accounting choices and applying conservative treatment. This shows what profits would look like under more prudent assumptions.
| Adjustment | As Reported (₹ Mn) | Adjustment | Restated (₹ Mn) | Rationale |
|---|---|---|---|---|
| Reported PBT (Consolidated) | 1,075 | — | 1,075 | Starting point |
| Less: Capitalized R&D (expense it) | — | (141) | 934 | R&D should be expensed as incurred |
| Less: Capitalized Employee R&D Costs | — | (54) | 880 | Salaries are operating costs |
| Less: Estimated Capitalized Borrowing Costs | — | (250) | 630 | Reverse interest capitalization |
| Less: Amortize Goodwill (10-yr life) | — | (165) | 465 | Goodwill ₹1,651 Mn / 10 years |
| Less: Additional ECL provision on Iskra receivables | — | (75) | 390 | ₹250 Cr non-current receivables need higher provision |
| Restated PBT (Conservative) | 1,075 | (685) | 390 | 64% lower than reported |
| Restated PAT (est. 24% tax) | 803 | — | ~296 | 63% lower than reported |
Under conservative accounting, FY25 consolidated PAT would be approximately ₹296 Mn — roughly one-third of the reported ₹803 Mn. The largest adjustments are: estimated borrowing cost capitalization (₹250 Mn), goodwill amortization (₹165 Mn), and R&D capitalization (₹195 Mn combined). This does NOT include any adjustment for the "reclassification" of consumables, which management has not quantified.
| Line Item | As Reported | Conservative Restated | Difference |
|---|---|---|---|
| Revenue from Operations | 27,218 | 27,218 | — |
| Total Expenses (ex-D&A, Finance) | 24,762 | 24,957 | +195 (R&D + employee capitalization reversed) |
| EBITDA | 2,456 | 2,261 | -195 |
| EBITDA Margin | 9.0% | 8.3% | -70 bps |
| Depreciation & Amortisation | 375 | 540 | +165 (goodwill amortization) |
| Finance Cost | 187 | 437 | +250 (borrowing cost de-capitalized) |
| Other Adjustments (ECL) | — | (75) | Additional provisioning |
| PBT | 1,075 | 390 | -685 (-64%) |
| PAT (est.) | 803 | ~296 | -507 (-63%) |
| PAT Margin | 2.9% | 1.1% | -180 bps |
Note: FY23 and FY24 had minimal acquisitions and lower capitalization — the gap between reported and conservative narrows in earlier years.
| Component | ₹ Cr (Est.) | % of Total | Nature |
|---|---|---|---|
| Core EMS Business | 3,250 | 72% | Organic |
| Iskraemeco (Smart Metering) | 500-600 | 12% | Acquired FY24 |
| August Electronics (Canada) | 175 | 4% | Acquired FY25 |
| OSAT (Sanand) | 100 | 2% | New Facility |
| Other Subsidiaries/JVs | ~475 | 10% | Mixed |
| Total | ~4,500 | 100% |
~72% of FY26 guided revenue is from core organic EMS operations. However, incremental growth (FY25→FY26) increasingly comes from acquired entities — Iskraemeco and August Electronics together may contribute ₹700-800 Cr of the ~₹1,780 Cr incremental revenue (~40-45% of growth is inorganic).
| Metric | FY23 Standalone | FY23 Consol. | FY25 Standalone | FY25 Consol. | Trend |
|---|---|---|---|---|---|
| Revenue (₹ Mn) | 10,866 | ~10,900 | 27,135 | 27,218 | Gap widening marginally |
| PAT (₹ Mn) | 948 | ~950 | 710 | 803 | Subsidiaries rescuing PAT |
| Total Assets (₹ Mn) | 14,000 | ~14,100 | 18,236 | 18,943 | ₹707 Mn in subsidiary assets |
FY25 standalone PAT fell to ₹710 Mn (from ₹948 Mn in FY23), but consolidated PAT was ₹803 Mn — meaning subsidiaries contributed ₹93 Mn in profit, effectively masking the standalone decline. In FY23, the subsidiary contribution was near-zero. Notably, no analyst on any of the concalls specifically questioned this standalone vs consolidated divergence as a line-by-line comparison.
| Subsidiary | FY24 Loans (₹ Mn) | FY25 Loans (₹ Mn) | Growth | Interest Earned (₹ Mn) | Status |
|---|---|---|---|---|---|
| Kaynes Electronics Mfg PL | 1,750 | 9,428 | +439% | 143 | ₹9.4B to pre-revenue entity! |
| Kaynes Semicon PL | 240 | 1,872 | +678% | 102 | OSAT capex funding |
| Kaynes Circuits India PL | 2 | 924 | +52,009% | 12 | PCB capex funding |
| Kaynes International D&M PL | 190 | 814 | +328% | — | International ops |
| Kaynes Mechatronics PL | 65 | 633 | +874% | 30 | Mechatronics |
| Iskraemeco India PL | — | 430 (investment) | — | — | Smart metering |
| Kemsys Technologies PL | — | 20 | — | 9 | Design services |
| TOTAL Inter-Co Loans | ~2,246 | ~13,690 | +510% | ~296 |
The parent company has lent ₹13.7 billion to its subsidiaries, with the largest recipient being Kaynes Electronics Manufacturing PL (₹9,428 Mn) which is a pre-revenue entity. This represents approximately 75% of standalone equity (₹18,236 Mn in assets). While the parent earns ₹296 Mn in interest income from these loans (helping standalone profitability), the recoverability depends entirely on these subsidiaries achieving commercial operations. If any major project fails, these loans could become impaired.
| Entity | Guarantee (₹ Mn) |
|---|---|
| Kaynes Electronics Manufacturing PL | 1,225 |
| Iskraemeco India PL | 700 |
| Kaynes International D&M PL | 181 |
| Total | 2,106 |
While Note 30 of the FY25 Annual Report contains detailed RPT disclosures as required under Ind AS 24, the Form AOC-2 (specific to Companies Act RPT disclosure in the Board's Report) does not appear to be explicitly referenced in the available sections. This form is mandatory for all material RPTs with related parties. Additionally, RPT transactions like the ₹1,625 Mn sale of materials to Iskraemeco need scrutiny — this is a subsidiary to which the parent simultaneously gave ₹700 Mn in corporate guarantees.
| Component | FY24 | FY25 | Change | Commentary |
|---|---|---|---|---|
| Salaries & Incentives | 939 | 1,583 | +69% | Acquisition-related headcount + buffering |
| PF Contribution | 30 | 60 | +97% | Proportional to salary increase |
| Gratuity | 16 | 31 | +91% | Higher headcount |
| Staff Welfare | 89 | 153 | +72% | Scale-up costs |
| ESOP Charges | 6 | 6 | Flat | Immaterial |
| Less: R&D Capitalized | (53) | (54) | Flat | Employee costs moved to intangible assets |
| Total (Consolidated) | 1,028 | 1,781 | +73% | |
| Total (Standalone) | 881 | 3,129 | +255% | Huge discrepancy! |
A major anomaly: FY25 standalone employee costs (₹3,129 Mn) appear to EXCEED consolidated employee costs (₹1,781 Mn). This is mathematically impossible unless there are significant inter-company eliminations or reclassifications happening during consolidation. This warrants deep investigation and may be related to the "reclassification" management referenced.
Management Explanation (Q3 FY25 call): Jairam Sampath: "The costs have kicked in, but revenues yet to kick in, and that's likely to happen in the fourth quarter." On Q4 FY25 call: "Employee costs have fared higher because we are currently buffering up the capacity, preparing for some 2 or 3 global engagements in FY'26."
| Component | FY24 | FY25 | Change% | Flag |
|---|---|---|---|---|
| Labour & Processing Charges | 222 | 500 | +126% | Subcontracting up |
| Stores & Spares | 190 | 400 | +111% | Reclassified from BOM? |
| ECL Provision | 135 | 194 | +43% | Iskraemeco receivables |
| Freight & Forwarding | 112 | 180 | +61% | Revenue growth related |
| Legal & Professional Fees | 89 | 166 | +87% | M&A advisory, statutory |
| Travel & Conveyance | 78 | 142 | +82% | Expansion related |
| Power & Fuel | 88 | 151 | +72% | New facility ramp-up |
| Insurance | 24 | 54 | +127% | Higher asset base |
| Rent | 6 | 30 | +385% | New facilities |
| Donations | 1 | 110 | +21,016% | ₹110 Mn donation — to whom? |
| CSR Expenditure | 13 | 31 | +140% | Statutory requirement |
| Business Promotion | 22 | 43 | +101% | Growth investment |
| Bank Charges | 25 | 45 | +80% | Higher borrowings |
When analyst Aksay asked about other expenses jumping from ₹31 Cr to ₹101 Cr in a single quarter, Jairam Sampath responded: "Some of the other expenses could be due to reclassification of certain consumables... it has more to do with reclassification than to increase in cost." This means materials previously shown under "Cost of Materials Consumed" were moved to "Other Expenses" — artificially lowering material cost % while inflating other expenses. This makes trend analysis across years unreliable without restating prior periods.
Donations surged from ₹0.52 Mn (FY24) to ₹110.08 Mn (FY25) — a 21,016% increase. This ₹11 Cr donation is separate from the ₹30.88 Mn CSR expenditure. The recipient and purpose of this donation is not detailed in the available notes. For context, this single donation equals ~14% of reported consolidated PAT.
| Segment | FY23 Share | FY26 Trend | Growth Driver | Margin Profile |
|---|---|---|---|---|
| Automotive | 38% | ~26% | EV penetration, OEM relationships | Above average |
| Industrial | 27% | Growing | Automation, IoT adoption | Average |
| Railways | 12% | Growing | Kavach program (₹34K Cr TAM) | High (ODM model) |
| Aerospace & Defence | 2% | ~10-12% | New marquee customer wins | Highest margin |
| Medical | 6% | Growing | New large customer | Above average |
| Smart Metering (NEW) | 0% | ~12-15% | Iskraemeco acquisition, RDSS | Volatile |
| Consumer/IT/IoT | 15% | ~12% | IT spending recovery | Below average |
| Geography | FY23 | FY25 | Commentary |
|---|---|---|---|
| India | 85% | 92.6% (₹25,202 Mn) | Domestic business growing faster |
| Rest of World | 15% | 7.4% (₹2,015 Mn) | Export share declining; August Electronics may reverse this |
| Entity | When | Consideration | Goodwill | Status | Revenue Contribution |
|---|---|---|---|---|---|
| Iskraemeco India Pvt Ltd Smart metering solutions |
Oct 2024 | ₹883 Mn | ₹1,140 Mn | Integrated | FY25: ₹412 Mn (sub revenue) 9M FY26: ~₹500 Cr |
| Sensonic Electronics Pvt Ltd AI-based railway safety |
FY25 | ₹453 Mn | ₹511 Mn | Integrating | FY25: ₹157 Mn Early stage |
| August Electronics Canadian EMS player |
Q4 FY25 | Not disclosed | Not disclosed | Integrating | FY26E: ₹175 Cr |
| Kemsys Technology Pvt Ltd Original subsidiary |
Pre-FY23 | — | — | Operational | Consolidated within group |
Consideration: ₹883 Mn. Goodwill: ₹1,140 Mn. Intangibles: ₹1,150 Mn. Total (₹2,290 Mn) is 2.6x the consideration — suggesting aggressive fair value allocation. Management acknowledged classification errors in Dec 2025 update. Additionally, the parent gave ₹700 Mn in corporate guarantees AND sold ₹1,625 Mn in materials to this subsidiary.
Net assets: ₹(58) Mn (negative). Consideration: ₹453 Mn. Goodwill: ₹511 Mn. The entire value is goodwill/intangibles — maximum impairment risk. If the railway safety technology doesn't deliver, ₹511 Mn in goodwill becomes write-off.
Investment in subsidiaries: ₹40 Mn (FY23) → ₹1,742 Mn (FY24) → ₹1,893 Mn (FY25). Inter-company loans: nil → ₹2,246 Mn → ₹13,690 Mn. The total capital deployed into subsidiaries (investments + loans) reached ₹15,583 Mn by FY25 — roughly 85% of standalone equity.
Design & engineering services entity
Listed on NSE/BSE. Proceeds for OSAT, PCB, general corporate
Tusshi Semiconductors, Kaynes Mechatronics, Kaynes Semicon, Kaynes Circuits, Kaynes Embedded Systems, Kaynes International D&M. Investments: ₹1,742 Mn
Smart metering. 125-person R&D team. Goodwill of ₹1,140 Mn + ₹1,150 Mn intangibles
AI railway safety. Negative net assets. Goodwill ₹511 Mn
Canadian EMS. North American footprint. FY26E revenue ₹175 Cr
Kaynes Circuits India Private Limited (a subsidiary) received approval for 4 projects in the first batch of the ECMS scheme. All projects are located in Tamil Nadu (Chennai region). Total approved investment: ₹3,280 Cr. Expected production: ₹28,315 Cr. Expected jobs: 2,480.
| # | Project | Investment (₹ Cr) | Expected Production (₹ Cr) | Jobs | Status (as of 9M FY26) |
|---|---|---|---|---|---|
| 1 | Multi-Layer PCB Standard multi-layer printed circuit boards |
104 | 4,300 | 220 | Phase 1 Under Construction ₹114 Cr spent on PCB as of Q1 FY26 |
| 2 | HDI PCB (High-Density Interconnect) Advanced PCB for mobile/automotive |
1,684 | 4,510 | 1,480 | Under Construction Phase 1 target: end of FY26. Total capex: ₹1,400 Cr combined PCB |
| 3 | Copper Clad Laminate (CCL) Base material for PCB manufacturing |
1,167 | 6,875 | 300 | Early Stage Part of backward integration strategy |
| 4 | Camera Module Sub-Assembly Camera modules for smartphones/automotive |
325 | 12,630 | 480 | Early Stage Not discussed in recent concalls |
| TOTAL | 3,280 | 28,315 | 2,480 |
Management stated on Q4 FY25 call: "50% of eligible capex comes from central government and another 20-25% from state government... 70% of the eligible capex comes from the government." This means ₹2,296 Cr of the ₹3,280 Cr investment is expected from government subsidies. If subsidies are delayed or reduced, the company would need to fund the shortfall from internal accruals or additional borrowings. The state government portion is contingent on "commencement of production" — creating a chicken-and-egg dependency.
ECMS approval for PCB projects alone: ₹3,280 Cr. Management has guided ₹1,400 Cr total for PCB facilities. The difference suggests phased execution — but the ECMS scheme expects committed investment within specified timelines for subsidy release. Only ₹114 Cr spent on PCB as of Q1 FY26, against ₹1,400 Cr target.
| Total Budgeted Capex | ₹3,400 Cr |
| Spent as of Q1 FY26 | ₹313 Cr |
| QIP Balance Remaining | ₹443 Cr |
| Loans from Parent (FY25) | ₹1,872 Mn |
| Interest Earned by Parent | ₹102 Mn |
| Govt Subsidy Expected | 70% of eligible |
| Commercial Ops Target | Q4 FY26 (delayed from FY24) |
| Total Budgeted Capex | ₹1,400 Cr |
| Spent as of Q1 FY26 | ₹114 Cr |
| Balance Remaining | ₹1,286 Cr |
| Loans from Parent (FY25) | ₹924 Mn |
| Interest Earned by Parent | ₹12 Mn |
| Govt Subsidy Expected | Via ECMS scheme |
| Phase 1 Target | End FY26 |
Step 1: Parent company (Kaynes Technology) lends money to subsidiaries as inter-corporate deposits/loans → shows as "Loans & Advances to Related Parties" on standalone balance sheet (₹13,690 Mn total).
Step 2: Subsidiaries use funds for land, building, equipment → shows as PPE/CWIP on subsidiary books.
Step 3: On consolidation, inter-company loans get eliminated. The CWIP/PPE appears directly on consolidated balance sheet (₹3,002 Mn CWIP in FY25).
Step 4: Parent earns interest income (₹296 Mn) from these loans, which gets eliminated on consolidation but inflates standalone "other income."
Net effect: Standalone profitability is ARTIFICIALLY boosted by ₹296 Mn in inter-company interest income. If the subsidiaries were divisions instead of separate entities, this income wouldn't exist. This is a legal but aggressive structural choice.
| Age | Amount | % |
|---|---|---|
| Less than 1 year | 2,424 | 81% |
| 1-2 years | 578 | 19% |
| Total CWIP | 3,002 | 100% |
81% of CWIP is less than 1 year old, which is consistent with the project timeline. However, the ₹578 Mn in 1-2 year CWIP (likely the OSAT project) means that facility has been under construction for over a year without generating revenue — consistent with the 2-year delay from original guidance.
Management stated on Q4 FY25 call: "So far as the OSAT and PCB, we basically bought the land and then some initial building work was done, land development, etcetera." This suggests a significant portion of CWIP is land and construction — legitimate. However, salary costs for employees hired for these facilities (management admitted to "buffering up capacity") could also be getting capitalized into CWIP under "preoperative expenses," which would inflate profits by keeping these costs off the P&L.
| # | Entity | Ownership | Purpose | Parent Loans (₹ Mn) | Revenue (₹ Mn) |
|---|---|---|---|---|---|
| 1 | Iskraemeco India Pvt Ltd | 100% | Smart Metering | 430 (inv) | 412 |
| 2 | Sensonic Electronics Pvt Ltd | Majority | Railway Safety | — | 157 |
| 3 | Kemsys Technologies Pvt Ltd | 100% | Design Services | 20 | — |
| 4 | Kaynes Electronics Mfg PL | 100% | OSAT/Manufacturing | 9,428 | Pre-revenue |
| 5 | Kaynes Semicon PL | 100% | OSAT Semiconductor | 1,872 | Pre-revenue |
| 6 | Kaynes Circuits India PL | 100% | PCB/HDI/CCL | 924 | Pre-revenue |
| 7 | Kaynes International D&M PL | 100% | International Ops | 814 | Pre-revenue |
| 8 | Kaynes Mechatronics PL | 100% | Mechatronics | 633 | Pre-revenue |
| 9 | Tusshi Semiconductors PL | 100% | Semiconductor | — | Pre-revenue |
| 10 | Kaynes Embedded Systems PL | 100% | Embedded Systems | — | Pre-revenue |
| 11 | August Electronics (Canada) | 100% | EMS (North America) | — | ~₹175 Cr* |
| TOTAL PARENT LOANS TO SUBS | 13,690 |
Only Iskraemeco (₹412 Mn), Sensonic (₹157 Mn), and August Electronics (~₹175 Cr estimated FY26) generate revenue. The remaining 8 entities are pre-revenue shells absorbing ₹13 billion in inter-company loans. These entities' capex is showing up as consolidated CWIP (₹3,002 Mn), with the parent effectively acting as a financing intermediary.
| Metric | FY23 | FY24 | FY25 | Q1 FY26 | Target |
|---|---|---|---|---|---|
| Net Working Capital Days | 99 | 83 | 87 | 132 | 70-85 |
| Inventory Days | ~120 | ~107 | ~110 | 115 | ~72 |
| Receivable Days | 69 | ~36 | ~66 | ~65 | ~50 |
| Payable Days | ~85 | ~55 | ~55 | ~48 | — |
| Commitment | When Made | Target | Actual | Status |
|---|---|---|---|---|
| FY24 Revenue Growth | Q4 FY23 | >30% | +17% (Standalone) | Missed |
| FY25 Revenue | Q4 FY24 | >₹3,000 Cr | ₹2,722 Cr (Consol.) | Missed (~91%) |
| FY25 EBITDA Margin | Q1 FY25 | 15% | 15.1% | Achieved |
| Order Book | Various | Strong growth | ₹6,597→₹9,000 Cr | Exceeded |
| NWC Days Target | Q3 FY24 | 70-85 days | 87-132 days | Consistently Missed |
| OSAT Commercial Ops | Q2 FY24 | Q4 FY24 | Q4 FY26 | Delayed 2 years |
| PCB Phase 1 | Q3 FY25 | End FY26 | In progress | Tracking |
| FY26 Revenue | Q4 FY25 | ₹4,500 Cr | 9M: ₹2,384 Cr | Needs strong Q4 |
| $1 Billion Revenue | Q3 FY24 | FY28 | Run-rate: ~₹3,200 Cr | Ambitious |
Revenue: ₹12,739 → ₹27,135 Mn (+113%). PAT: ₹1,202 → ₹710 Mn (-41%). Employee costs surged 255%, other expenses 315%. Management cited: (a) "reclassification of consumables" for other expenses, (b) "buffering capacity for global engagements" for employee costs. Neither explanation is fully satisfactory for the magnitude of divergence.
₹1,261 Mn → ₹4,918 Mn. Iskraemeco legacy receivables of ₹250 Cr classified as non-current. ECL provision of ₹194 Mn may be insufficient.
FY25 standalone employee cost: ₹3,129 Mn. FY25 consolidated employee cost: ₹1,781 Mn. This arithmetic impossibility suggests major reclassification or consolidation adjustment that isn't transparently disclosed.
Parent has lent ₹13,690 Mn to subsidiaries, mostly pre-revenue entities. Recoverability depends on projects achieving commercial production. If any major project fails, these become impaired.
CFO explicitly stated on Q4 FY25 call that the other expense surge was "reclassification" not cost increase. This breaks YoY comparability without formal restatement of prior periods.
Dec 2025 business update: management acknowledged disclosure errors in goodwill vs intangible asset classification requiring reclassification. Internal control weakness signal.
Donations jumped from ₹0.52 Mn to ₹110 Mn. Equals ~14% of consolidated PAT. Recipient and purpose undisclosed in available notes.
Borrowings: ₹2,641 → ₹3,991 Mn (+51%). Finance costs: ₹535 → ₹187 Mn (-65%). Implies massive borrowing cost capitalization, reducing reported expenses.
₹117 Mn (FY23) → ₹642 Mn (FY24) → ₹227 Mn (FY25). FY24 inflated by IPO proceeds interest. FY25 includes ₹296 Mn inter-company interest from subsidiaries.
Originally guided Q4 FY24, now targeting Q4 FY26. ₹3,400 Cr capex project with only ₹313 Cr spent. Government subsidy contingent on production commencement.
While Note 30 has RPT details, the mandatory Form AOC-2 in the Board's Report is not clearly referenced in available sections. This form is required under Companies Act for all material RPTs.
Of ₹13,740 Mn raised: only ₹1,620 Mn (12%) deployed as at FY24 end. 88% parked in deposits.
| Year | Auditor | Opinion | Key Audit Matters |
|---|---|---|---|
| FY23 | K.P. Rao & Co. | Unqualified | Revenue Recognition |
| FY24 | K.P. Rao & Co. | Unqualified | Revenue Recognition |
| FY25 | K.P. Rao & Co. | Unqualified | Revenue Recognition, Goodwill Valuation, Capitalization of Assets, Subsidiary Consolidation |
Same auditor 3 years running. FY25 KAM expanded from 1 to 4 areas — auditor flagging more judgment-intensive areas. Clean opinions provide some comfort. Contingent liabilities grew from ₹28 Mn (FY23) to ₹136 Mn (FY25).
Source: Kotak Institutional Equities ESG Update — "Kaynes Technology FY2025 Annual Report Analysis" | December 3, 2025 | Analysts: Sandeep Gupta, Prateeksha Malpani, Shubham Khanna
Kotak identified 7 primary concerns in their executive summary, which expand into ~20 specific issues across 22 pages. Below is every issue raised, Kaynes' clarification (from Dec 5, 2025 response), and our independent assessment.
| Aspect | Details |
|---|---|
| Kotak's Concern | Iskraemeco contributed ₹489 Mn to consolidated PAT in just 6 months (2H FY25) — yet its standalone PAT was only ₹5.37 Mn for the full year. This implies a 28% net margin in 2H FY25, which is implausible for a smart metering business. There's a ₹483 Mn loss in 1H FY25 that cannot be reconciled with full-year profit of ₹6 Mn. Acquisition payback in <6 months is unusually fast. |
| Kaynes' Clarification | No specific clarification was provided on this point in the Dec 5, 2025 response. |
| Our Take | Major Red Flag This is the single most damning finding. Iskraemeco's standalone accounts show PAT of just ₹5.37 Mn — yet consolidation adds ₹489 Mn in profit. The gap of ₹483 Mn in a single entity's contribution suggests either: (a) aggressive purchase price allocation creating favorable amortization; (b) inter-company transactions inflating consolidated profit; or (c) consolidation adjustments that flatter the numbers. We had flagged the 28% margin anomaly but missed the standalone vs. consolidated PAT gap at the Iskraemeco entity level. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Goodwill of ₹1,140 Mn recognized from acquisitions, but consolidated BS shows a NET NEGATIVE adjustment of ₹10 Mn in goodwill — unexpected given acquisitions. ₹61 Mn rise in general reserves appears offset against goodwill. No fair value adjustment disclosures despite ₹1 Bn in intangible additions. Acquisition payment of ₹725 Mn (₹883 Mn less ₹158 Mn contingent) not shown as cash outflow. |
| Kaynes' Clarification | Invoked Ind AS 103 to justify recognizing intangible assets from acquisitions. Stated "Customer Contracts can be recognised as an Intangible Asset." Claimed intangible assets were "netted off with the goodwill." |
| Our Take | Deflective Response We had flagged goodwill classification errors. Kotak goes deeper by identifying the negative goodwill adjustment on the consolidated BS and the hidden cash outflows. Management's response cites accounting standards but doesn't explain the specific amounts, netting logic, or why fair value adjustments weren't disclosed. The hiding of ₹725 Mn acquisition cash outflow in consolidation entries is a new concern we missed. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Additions under "technical know-how, including designs and prototypes" jumped from ₹138 Mn (FY24) to ₹1,767 Mn (FY25) — a 13x increase. R&D capitalization rate: 94% (only 6% expensed). Compared to historical pattern: FY21-24 averaged ₹130 Mn/year. |
| Kaynes' Clarification | Broke down into: Customer contracts ₹115 Cr, Iskraemeco development ₹26 Cr, In-house R&D ₹39 Cr. Total: ₹180 Cr — but Kotak identified ₹1,767 Mn, a discrepancy. |
| Our Take | Evasive Response We had flagged this in our Section 4. Kotak adds the critical historical context showing this was a 13x spike from steady-state levels. Management's breakdown totals ₹180 Cr (₹1,800 Mn) — roughly matching. The key issue is ₹115 Cr in "customer contract" intangibles from the Iskraemeco acquisition, which management tries to separate from "technical know-how" but Kotak correctly lumps together. 94% R&D capitalization rate is aggressive by any standard. |
| Aspect | Details |
|---|---|
| Kotak's Concern | ITAUD balance: ₹911 Mn (of which ₹866 Mn is "Technical Know-How Under Development"). Additions of ₹686 Mn vs. capitalizations of only ₹60 Mn — meaning most development never reaches completion. Starting balance was ₹143 Mn (FY23), now 6.4x higher. |
| Kaynes' Clarification | Not specifically addressed. |
| Our Take | Concerning We mentioned growing ITAUD but didn't have the full ₹911 Mn figure or the capitalization-to-addition ratio (only 9% of additions actually completed). ₹866 Mn parked in "designs and prototypes under development" with minimal conversion suggests either: (a) projects are stalling; (b) the company is using ITAUD as a parking lot for expenses that should be written off; or (c) long development cycles are genuine. The low capitalization rate is a red flag. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Iskraemeco's standalone shows: (a) Purchases of ₹1.8 Bn from Kaynes Electronics Manufacturing — NOT reflected in KEM's RPT disclosures; (b) Year-end payables of ₹3.2 Bn to Kaynes Technology and ₹1.8 Bn to KEM — NOT in their disclosures; (c) Receivables of ₹1.9 Bn from Kaynes Technology — NOT in Kaynes' standalone disclosures. Total missing: ~₹6.8 Bn. |
| Kaynes' Clarification | "These related party transactions were eliminated in the consolidated financial statements... However, they were inadvertently not disclosed in the standalone financial statements. This has since been rectified." |
| Our Take | Governance Failure We had flagged RPT concerns but Kotak's analysis is far more specific — identifying ₹6.8 Bn in completely missing one-way disclosures. Management's excuse of "inadvertent" omission is not credible for amounts this material. Elimination during consolidation does NOT exempt standalone disclosure requirements. This is a Companies Act compliance failure. The identical copy-paste response for Issues 3 and 4 suggests management didn't take the concerns seriously. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Consolidated CCC: 135→157 days (+22 days). Kaynes Electronics Manufacturing CCC: 68→187 days (+119 days). Standalone including related-party advances: 267→354 days. Iskraemeco has negative CCC: (395)→(53) days — suggesting unsustainable supplier payment delays. |
| Kaynes' Clarification | Not specifically addressed in the Dec 5 response. |
| Our Take | Confirmed Our Findings We had flagged NWC days at 87-132 but Kotak's consolidated CCC of 157 days is worse than our estimates. The KEM CCC explosion (+119 days) and standalone CCC of 354 days (including RPT advances) are figures we didn't have. Iskraemeco's negative CCC suggests it's paying suppliers very late — which may inflate short-term profitability at the cost of supplier relationships. |
| Aspect | Details |
|---|---|
| Kotak's Concern | OCF post-interest was negative ₹0.9 Bn in FY25. FCF was negative ₹10.4 Bn (after ₹9.5 Bn capex). 5-year cumulative FCF is deeply negative. Negative FCF in 4 of 5 years (FY21-FY25). Working capital consumed ₹2.7 Bn of cash in FY25, with receivables alone consuming ₹2.2 Bn and loans/advances consuming ₹4.1 Bn. |
| Kaynes' Clarification | Not specifically addressed. |
| Our Take | We Underestimated This We noted FY23 negative OCF but Kotak shows the problem is structural — 4 of 5 years with negative FCF. The FY25 FCF of negative ₹10.4 Bn is staggering — the company is burning cash at an alarming rate. The ₹4.1 Bn consumed by loans and advances confirms our concern about inter-company lending absorbing cash. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Cash flow statement shows ₹9.5 Bn capex outflow but BS additions (PPE + CWIP + Intangibles + ITAUD) total only ₹7.7 Bn. After adjustments: ₹0.4 Bn from acquisition-PPE should be in acquisition cash flow, and ₹1.7 Bn in ROU additions (99-year leases on land) aren't truly capital-intensive. Govt subsidy of ₹429 Mn further complicates ROU. |
| Kaynes' Clarification | Not addressed. |
| Our Take | We Missed This Entirely This capex reconciliation gap is a significant finding we did not catch. The ₹1.8 Bn variance between cash capex and BS additions needs clear explanation. If ₹0.4 Bn of PPE from acquisitions is buried in capex line instead of acquisition outflow, it inflates organic capex appearance. The 99-year lease/ROU complexity further obscures true capital spending. |
| Aspect | Details | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kotak's Concern |
| ||||||||||||||||||||||||||||
| Kaynes' Clarification | Broke down additions: Performance Bank Guarantee for Iskraemeco: ₹96.8 Cr; Corporate guarantees: Kaynes Electronics ₹122.5 Cr + Iskraemeco ₹70 Cr. Stated these were "necessitated due to funding requirements at Iskraemeco." | ||||||||||||||||||||||||||||
| Our Take | We Significantly Underestimated Our report showed contingent liabilities growing from ₹28 Mn to ₹136 Mn (standalone data). Kotak's consolidated figure of ₹5,207 Mn (18.3% of net worth) is vastly larger. The bank guarantee explosion from ₹67 Mn to ₹1,040 Mn (15x) is alarming. Management's clarification explains only part of the increase and does not address probability of crystallization. |
| Aspect | Details | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kotak's Concern |
| |||||||||||||||||||||
| Kaynes' Clarification | Not addressed. | |||||||||||||||||||||
| Our Take | We Missed This Entirely The explosion of bad debt provisions from ₹194 Mn (full FY25) to ₹552 Mn (just 1H FY26) is a critical finding. At 2.3% of revenue, this signals serious customer credit stress — likely from the smart metering receivables. The ₹6 Bn in discounted long-term receivables adds another layer of contingent risk. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Consolidated debt surged to ₹8,755 Mn (up 186% from ₹3,061 Mn). Interest: ₹1,047 Mn. Average borrowing cost: 17.7%. Closing cost: 12%. Historical average has ranged from 13-25%. |
| Kaynes' Clarification | "We need to consider bill discounting. The interest cost will work out to 10% including bill discounting." Claimed FY24 comparable was 25.3%. |
| Our Take | Partially Valid Response Including bill discounting to get to 10% is a reasonable adjustment. However, 10% is still above prime lending rates. The bigger issue we missed: consolidated debt is ₹8,755 Mn — far higher than our standalone figure of ₹3,991 Mn. The subsidiary borrowings add ₹4,764 Mn in additional debt not visible in standalone statements. |
| Aspect | Details | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kotak's Concern |
| ||||||||||||||||||||||||
| Kaynes' Clarification | Not specifically addressed. | ||||||||||||||||||||||||
| Our Take | Scale of Commitment Understated by Us We had the ECMS project details but didn't sum up the total remaining commitment this clearly. ₹36 Bn remaining on PCB projects alone. The company needs to spend multiples of its current annual revenue on capex, while generating negative FCF. This is a classic "bet-the-company" investment cycle that needs government subsidies to work. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Iskraemeco's trade receivables grew from ₹565 Mn to ₹1,053 Mn (+86%). ₹618 Mn is in 6-month to 1-year bucket. ₹33 Mn is >3 years old. These are receivables from government/utility customers with uncertain collection timelines. |
| Kaynes' Clarification | Not addressed. |
| Our Take | We Had Partial Data We flagged the ₹250 Cr non-current receivables but Kotak's entity-level aging analysis is more granular. The concentration risk in 6-12 month receivables (₹618 Mn) and the appearance of >3 year receivables (₹33 Mn) are concerning for a recently acquired entity. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Net foreign currency exposure increased from ₹1.6 Bn (FY24) to ₹2.0 Bn (FY25) — primarily USD-denominated payables. Growing FX risk without evident hedging disclosures. |
| Kaynes' Clarification | Not addressed. |
| Our Take | We Missed This We didn't analyze FX exposure. For a company importing components and with growing international operations (August Electronics Canada), ₹2 Bn in unhedged FX exposure represents ~7% of revenue. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Revenue growth decelerated from 60% (FY24) to 51% (FY25) DESPITE Iskraemeco's 6-month revenue contribution. Implies organic growth slowed meaningfully — possibly to ~30-35% excluding Iskraemeco. |
| Kaynes' Clarification | Not addressed. |
| Our Take | Valid Concern We noted that growth was increasingly inorganic but didn't explicitly flag the deceleration from 60% to 51%. The fact that growth slowed even after adding a ₹6.2 Bn revenue acquisition means organic growth has slowed substantially. |
| Aspect | Details |
|---|---|
| Kotak's Concern | Over FY21-25: 72% of funds came from equity issuances. Of deployed funds, 40% went to FDs/MFs rather than operations. Company raised ₹34.7 Bn via IPO/QIPs since Nov 2022. Yet still requires debt for capex. Investment corpus down ₹4.7 Bn (₹16,573 Mn → ₹11,887 Mn) suggesting liquidity buffer shrinking. |
| Kaynes' Clarification | Not addressed. |
| Our Take | We Partially Caught This We flagged the fund utilization lag (88% in deposits as of FY24) but Kotak's analysis spanning 5 years is more comprehensive. The 72% equity-funded growth model is dilutive to existing shareholders. The shrinking investment corpus while capex needs are enormous (₹61+ Bn remaining) points to a potential funding gap. |
| # | Kotak Issue | Our Coverage | Severity |
|---|---|---|---|
| 1 | Iskraemeco standalone PAT ₹5.37 Mn vs ₹489 Mn consolidated contribution | MISSED | Critical — suggests consolidation manipulation |
| 2 | Cash capex (₹9.5B) vs BS additions (₹7.7B) — ₹1.8B mismatch | MISSED | High — asset classification opacity |
| 3 | Bad debt provisions spiked to ₹552 Mn in 1H FY26 (2.3% of revenue) | MISSED | Critical — customer credit stress |
| 4 | ₹6 Bn in smart metering receivables discounted in Q2 FY26 | MISSED | High — contingent liability and earnings quality |
| 5 | 5-year cumulative negative FCF; FY25 FCF = negative ₹10.4 Bn | PARTIAL | Critical — structural cash burn |
| 6 | Consolidated debt ₹8,755 Mn (we had only standalone ₹3,991 Mn) | PARTIAL | High — true leverage understated |
| 7 | Contingent liabilities ₹5,207 Mn consolidated (we had ₹136 Mn standalone) | PARTIAL | High — 38x larger than our figure |
| 8 | Bank guarantees exploded 15x (₹67 → ₹1,040 Mn) | MISSED | High — execution/contractual risk |
| 9 | Net FX exposure ₹2.0 Bn | MISSED | Medium — currency risk unhedged |
| 10 | Revenue growth decelerated 60%→51% despite acquisition | PARTIAL | Medium — organic slowdown |
| 11 | ITAUD balance ₹911 Mn with only 9% conversion rate | PARTIAL | Medium — impairment risk |
| 12 | ROU assets/99-year lease complexity (₹1.7 Bn) | MISSED | Medium — asset classification |
| 13 | 72% equity-funded growth; investment corpus shrinking | PARTIAL | Medium — dilution and funding gap |
| 14 | Acquisition cash outflow (₹725 Mn) hidden in consolidation | MISSED | Medium — cash flow presentation |
Our analysis caught the broad themes (aggressive accounting, RPT issues, capitalization, working capital) but missed several entity-level forensic details that Kotak identified. The most damaging miss was Iskraemeco's standalone PAT of just ₹5.37 Mn vs. ₹489 Mn consolidated contribution — this single data point undermines the entire acquisition thesis. Our reliance on standalone data also caused us to significantly understate consolidated debt (₹8.8B vs our ₹4.0B) and contingent liabilities (₹5.2B vs our ₹136 Mn).
| Issue | Response Quality | Verdict |
|---|---|---|
| Goodwill Treatment | Cited Ind AS 103, no specific amounts | Deflective |
| Contingent Liabilities | Provided partial breakdown | Partial |
| ₹1.8B RPT Missing (purchases) | "Inadvertently not disclosed" | Evasive |
| ₹6.8B RPT Balances Missing | Same "inadvertent" response | Evasive |
| Borrowing Cost 17.7% | Adjusted for bill discounting → 10% | Partially Valid |
| ₹1.8B Intangible Capitalization | Provided breakdown, but vague justifications | Marginally Helpful |
| Overall | 4 of 6 responses deflective or evasive | Poor Quality |
| Dimension | Rating | Commentary |
|---|---|---|
| Revenue Growth Quality | 6/10 | Strong topline but ~40-45% of incremental growth is inorganic |
| Earnings Quality | 4/10 | Conservative restated PAT is 63% lower than reported; standalone PAT declining; expense reclassification admitted |
| Accounting Conservatism | 3/10 | Aggressive capitalization, goodwill errors, expense reclassification, inter-co lending inflating standalone income |
| Cash Flow Quality | 5/10 | NWC persistently above guidance; receivable spikes; ₹13.7B trapped in subsidiary loans |
| Disclosure Transparency | 5/10 | RPT disclosed in notes but AOC-2 unclear; donation unexplained; reclassification not formally restated |
| Management Execution | 6/10 | Margins met; revenue targets missed; OSAT delayed 2 years; strong order book |
| Capital Allocation | 5/10 | ₹15.6B deployed into subsidiaries (85% of equity); heavy govt subsidy dependency |
| Corporate Governance | 6/10 | Clean audit opinions; but same auditor 3 years; goodwill errors; unexplained donations |
Kaynes Technology exhibits characteristics of a high-growth EMS company with aggressive accounting practices that materially inflate reported profitability. Key findings:
1. Reported profits are significantly overstated. Under conservative accounting, FY25 consolidated PAT drops from ₹803 Mn to ~₹296 Mn — a 63% reduction. The largest drivers are estimated borrowing cost capitalization, goodwill that isn't being amortized, and R&D expense capitalization.
2. The standalone company is struggling. Revenue doubled in FY25 but PAT halved. Employee costs and other expenses surged disproportionately, with management admitting the latter was "reclassification." Standalone profits are also artificially boosted by ₹296 Mn in inter-company interest income from ₹13.7B in subsidiary loans.
3. Growth quality is deteriorating. ~40-45% of incremental FY26 growth is inorganic. 8 of 11 subsidiaries are pre-revenue. The company is running 4 ECMS mega-projects simultaneously while integrating 3 acquisitions — all with significant government subsidy dependency.
4. Working capital and cash conversion remain weak. NWC days consistently exceed guidance. Trade receivables growing faster than revenue. ₹250 Cr in Iskraemeco non-current receivables.
5. The positive case: The ₹9,000 Cr order book (growing 49% YoY) is genuinely strong. EBITDA margins are holding. Expansion into aerospace, railways (Kavach), and semiconductor OSAT could create significant value if executed well. The company is positioning itself in India's electronics manufacturing value chain at a time of favorable policy tailwinds.
This analysis is based solely on publicly available information from annual reports and concall transcripts. It is not investment advice. All "restated" figures are estimates based on available data and involve assumptions that may not reflect actual accounting treatment.